On 30 January 2020, the WHO declared COVID-19 a public health emergency of international concern (PHEIC). Healthcare scientists have been working diligently to develop therapeutics to combat the contagion, save lives, and reduce the adverse impact on livelihoods.

There’s a lot of pressure on biopharma companies and their input suppliers to bring routine medications and immune system boosters to the market faster.